Algert Global’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,287
| Closed | -$882K | – | 1201 |
|
|
2025
Q1 | $882K | Sell |
26,287
-2,490
| -9% | -$83.5K | 0.02% | 796 |
|
|
2024
Q4 | $1.47M | Sell |
28,777
-14,000
| -33% | -$716K | 0.03% | 705 |
|
|
2024
Q3 | $2.19M | Buy |
42,777
+1,070
| +3% | +$54.7K | 0.06% | 524 |
|
|
2024
Q2 | $1.87M | Buy |
41,707
+6,667
| +19% | +$299K | 0.06% | 489 |
|
|
2024
Q1 | $1.64M | Buy |
35,040
+17,360
| +98% | +$813K | 0.06% | 474 |
|
|
2023
Q4 | $629K | Buy |
+17,680
| New | +$629K | 0.03% | 749 |
|
|
2023
Q2 | – | Sell |
-18,710
| Closed | -$300K | – | 1113 |
|
|
2023
Q1 | $300K | Buy |
18,710
+1,304
| +7% | +$20.9K | 0.01% | 947 |
|
|
2022
Q4 | $319K | Hold |
17,406
| – | – | 0.02% | 921 |
|
|
2022
Q3 | $342K | Sell |
17,406
-2,673
| -13% | -$52.5K | 0.02% | 915 |
|
|
2022
Q2 | $374K | Sell |
20,079
-4,880
| -20% | -$90.9K | 0.03% | 857 |
|
|
2022
Q1 | $548K | Buy |
+24,959
| New | +$548K | 0.04% | 773 |
|